These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 8197420)

  • 21. Familial thyroid disease and delayed language development in first admission patients with schizophrenia.
    DeLisi LE; Boccio AM; Riordan H; Hoff AL; Dorfman A; McClelland J; Kushner M; Van Eyl O; Oden N
    Psychiatry Res; 1991 Jul; 38(1):39-50. PubMed ID: 1946833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flat affect in schizophrenia: a test of neuropsychological models.
    Blanchard JJ; Kring AM; Neale JM
    Schizophr Bull; 1994; 20(2):311-25. PubMed ID: 8085134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-selective impairment of Wisconsin Card Sorting Test performance in patients with schizophrenia.
    Dieci M; Vita A; Silenzi C; Caputo A; Comazzi M; Ferrari L; Ghiringhelli L; Mezzetti M; Tenconi F; Invernizzi G
    Schizophr Res; 1997 May; 25(1):33-42. PubMed ID: 9176925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).
    Nuechterlein KH; Green MF; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Light GA; Radant AD; Seidman LJ; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL
    Schizophr Res; 2015 Apr; 163(1-3):38-46. PubMed ID: 25749017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A theory of dopamine function and its role in cognitive deficits in schizophrenia.
    Cohen JD; Servan-Schreiber D
    Schizophr Bull; 1993; 19(1):85-104. PubMed ID: 8095737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the concept of frontal-subcortical dementia relevant to schizophrenia?
    Pantelis C; Barnes TR; Nelson HE
    Br J Psychiatry; 1992 Apr; 160():442-60. PubMed ID: 1349250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained attention deficits as markers of genetic susceptibility to schizophrenia.
    Chen WJ; Faraone SV
    Am J Med Genet; 2000; 97(1):52-7. PubMed ID: 10813804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development.
    Germine L; Robinson EB; Smoller JW; Calkins ME; Moore TM; Hakonarson H; Daly MJ; Lee PH; Holmes AJ; Buckner RL; Gur RC; Gur RE
    Transl Psychiatry; 2016 Oct; 6(10):e924. PubMed ID: 27754483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficits assessed by Continuous Performance Test and Span of Apprehension Test in Japanese schizophrenic patients.
    Ito M; Kanno M; Mori Y; Niwa S
    Schizophr Res; 1997 Feb; 23(3):205-11. PubMed ID: 9075298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attentional vulnerability indicators in schizophrenia and bipolar disorder.
    Addington J; Addington D
    Schizophr Res; 1997 Feb; 23(3):197-204. PubMed ID: 9075297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia.
    Cornblatt BA; Malhotra AK
    Am J Med Genet; 2001 Jan; 105(1):11-5. PubMed ID: 11424979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic markers as risk factors in schizophrenia: neurocognitive functions.
    Michie PT; Kent A; Stienstra R; Castine R; Johnston J; Dedman K; Wichmann H; Box J; Rock D; Rutherford E; Jablensky A
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S74-85. PubMed ID: 11129319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parallel distributed processing and the emergence of schizophrenic symptoms.
    Hoffman RE; McGlashan TH
    Schizophr Bull; 1993; 19(1):119-40. PubMed ID: 8451607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex-onset effects on neuropsychological function in schizophrenia.
    Lewine R; Haden C; Caudle J; Shurett R
    Schizophr Bull; 1997; 23(1):51-61. PubMed ID: 9050112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive disorders in psychiatry: a case example of diagnostic and treatment dilemmas.
    Weinstein CS; Seidman LJ; Feldman JJ; Ratey JJ
    Psychiatry; 1991 Feb; 54(1):65-75; discussion 76-7. PubMed ID: 2023975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients.
    Zalewski C; Johnson-Selfridge MT; Ohriner S; Zarrella K; Seltzer JC
    Schizophr Bull; 1998; 24(1):127-45. PubMed ID: 9502551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.
    Young JW; Geyer MA; Rissling AJ; Sharp RF; Eyler LT; Asgaard GL; Light GA
    Transl Psychiatry; 2013 Nov; 3(11):e324. PubMed ID: 24217494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobehavioral studies in schizophrenia: implications for regional brain dysfunction.
    Gur RE; Gur RC; Saykin AJ
    Schizophr Bull; 1990; 16(3):445-51. PubMed ID: 2287934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic and neuropsychological components of defect states.
    Bilder RM; Mukherjee S; Rieder RO; Pandurangi AK
    Schizophr Bull; 1985; 11(3):409-19. PubMed ID: 4035304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On familial factors in the attentional deficit in schizophrenia: a review and report of two new subject samples.
    Mirsky AF; Lochhead SJ; Jones BP; Kugelmass S; Walsh D; Kendler KS
    J Psychiatr Res; 1992 Oct; 26(4):383-403. PubMed ID: 1491359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.